Toll-like receptors in Leishmania infections: Guardians or promoters?

Journal of Parasitology Research

Volumn 2012, Issue , 2012, Pages

  Faria, Marilia S ^a   Reis, Flavia C G ^a   Lima, Ana Paula C A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPHOSPHOGLYCAN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TYROSINE PHOSPHATASE SHP 1; REACTIVE OXYGEN METABOLITE; SILENT INFORMATION REGULATOR PROTEIN 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVATION; GENE MUTATION; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LEISHMANIASIS; NONHUMAN; PARASITE CONTROL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; UPREGULATION;

PROTOZOA;

EID: 84859739788     PISSN: 20900023     EISSN: 20900031     Source Type: Journal    
DOI: 10.1155/2012/930257     Document Type: Review

References (97)

1. Kaye P., Scott P., Leishmaniasis: complexity at the host-pathogen interface Nature Reviews Microbiology 2011 9 8 604 615
2. Follador I., Arajo C., Bacellar O., Arajo C. B., Carvalho L. P., Almeida R. P., Carvalho E. M., Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection Clinical Infectious Diseases 2002 34 11 E54 E58
3. Bosque F., Saravia N. G., Valderrama L., Milon G., Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection Scandinavian Journal of Immunology 2000 51 5 533 541 (Pubitemid 30253216)
4. Travi B., Rey-Ladino J., Saravia N. G., Behavior of Leishmania braziliensis s.l. in golden hamsters: evolution of the infection under different experimental conditions Journal of Parasitology 1988 74 6 1059 1062 (Pubitemid 19011790)
5. Ameen M., Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics Clinical and Experimental Dermatology 2010 35 7 699 705
6. Amato V. S., Tuon F. F., Bacha H. A., Neto V. A., Nicodemo A. C., Mucosal leishmaniasis. Current scenario and prospects for treatment Acta Tropica 2008 105 1 1 9 (Pubitemid 350262798)
7. David C. V., Craft N., Cutaneous and mucocutaneous leishmaniasis Dermatologic Therapy 2009 22 6 491 502
8. de Oliveira Guerra J. A., Prestes S. R., Silveira H., Coelho L. I.A.R.C., Gama P., Moura A., Amato V., Barbosa M. G.V., de Lima Ferreira L. C., Mucosal leishmaniasis caused by leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon PLoS Neglected Tropical Diseases 2011 5 3, article e980
9. Schriefer A., Wilson M. E., Carvalho E. M., Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis Current Opinion in Infectious Diseases 2008 21 5 483 488
10. Kaye P. M., Aebischer T., Visceral leishmaniasis: immunology and prospects for a vaccine Clinical Microbiology and Infection 2011 17 10 1462 1470
11. Nylen S., Gautam S., Immunological perspectives of leishmaniasis Journal of Global Infectious Diseases 2010 2 135 146
12. Dalton J. E., Maroof A., Owens B. M. J., Narang P., Johnson K., Brown N., Rosenquist L., Beattie L., Coles M., Kaye P. M., Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice Journal of Clinical Investigation 2010 120 4 1204 1216
13. Sacks D., Noben-Trauth N., The immunology of susceptibility and resistance to Leishmania major in mice Nature Reviews Immunology 2002 2 11 845 858 (Pubitemid 37328707)
14. Liese J., Schleicher U., Bogdan C., The innate immune response against Leishmania parasites Immunobiology 2008 213 3-4 377 387
15. Blos M., Schleicher U., Soares Rocha F. J., Meiner U., Rllinghoff M., Bogdan C., Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase European Journal of Immunology 2003 33 5 1224 1234 (Pubitemid 36609140)
16. Rocha F. J. S., Schleicher U., Mattner J., Alber G., Bogdan C., Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice Infection and Immunity 2007 75 8 3823 3832 (Pubitemid 47206279)
17. Murray H. W., Nathan F., Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani Journal of Experimental Medicine 1999 189 4 741 746 (Pubitemid 29193376)
18. Murray H. W., Xiang Z., Ma X., Short report: responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase American Journal of Tropical Medicine and Hygiene 2006 74 6 1013 1015 (Pubitemid 351627408)
19. Murray H. W., Berman J. D., Davies C. R., Saravia N. G., Advances in leishmaniasis Lancet 2005 366 9496 1561 1577 (Pubitemid 41540115)
20. Pifer R., Benson A., Sturge C. R., Yarovinsky F., UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii Journal of Biological Chemistry 2011 286 5 3307 3314
21. Blasius A. L., Beutler B., Intracellular Toll-like receptors Immunity 2010 32 3 305 315
22. Kawai T., Akira S., Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity Immunity 2011 34 5 637 650
23. Prince L. R., Whyte M. K., Sabroe I., Parker L. C., The role of TLRs in neutrophil activation Current Opinion in Pharmacology 2011 11 4 397 403
24. Hayashi F., Means T. K., Luster A. D., Toll-like receptors stimulate human neutrophil function Blood 2003 102 7 2660 2669 (Pubitemid 37193610)
25. Oliveira A.-C., Peixoto J. R., De Arrada L. B., Campos M. A., Gazzinelli R. T., Golenbock D. T., Akira S., Previato J. O., Mendona-Previato L., Nobrega A., Bellio M., Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi Journal of Immunology 2004 173 9 5688 5696 (Pubitemid 39392157)
26. Coban C., Ishii K. J., Kawai T., Hemmi H., Sato S., Uematsu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T., Akira S., Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin Journal of Experimental Medicine 2005 201 1 19 25 (Pubitemid 40130079)
27. Carrera L., Gazzinelli R. T., Badolato R., Hieny S., Mller W., Khn R., Sacks D. L., Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice Journal of Experimental Medicine 1996 183 2 515 526 (Pubitemid 26059515)
28. Belkaid Y., Butcher B., Sacks D. L., Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells European Journal of Immunology 1998 28 4 1389 1400
29. Hawn T. R., Ozinsky A., Underhill D. M., Buckner F. S., Akira S., Aderem A., Leishmania major activates IL-1 expression in macrophages through a MyD88-dependent pathway Microbes and Infection 2002 4 8 763 771 (Pubitemid 35247439)
30. Yarovinsky F., Zhang D., Andersen J. F., Bannenberg G. L., Serhan C. N., Hayden M. S., Hieny S., Sutterwala F. S., Flavell R. A., Ghosh S., Sher A., Immunology: TLR11 activation of dendritic cells by a protozoan profilin-like protein Science 2005 308 5728 1626 1629 (Pubitemid 40807512)
31. Kavoosi G., Ardestani S. K., Kariminia A., The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs) Parasitology 2009 136 10 1193 1199
32. Ilg T., Stierhof Y. D., Wiese M., McConville M. J., Overath P., Characterization of phosphoglycan-containing secretory products of Leishmania Parasitology 1994 108 S63 S71 (Pubitemid 24236813)
33. Osanya A., Song E.-H., Metz K., Shimak R. M., Boggiatto P. M., Huffman E., Johnson C., Hostetter J. M., Pohl N. L.B., Petersen C. A., Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infection American Journal of Pathology 2011 179 3 1329 1337
34. de Veer M. J., Curtis J. M., Baldwin T. M., DiDonato J. A., Sexton A., McConville M. J., Handman E., Schofield L., MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling European Journal of Immunology 2003 33 10 2822 2831 (Pubitemid 37337148)
35. Campos M. A. S., Almeida I. C., Takeuchi O., Akira S., Valente E. P., Procpio D. O., Travassos L. R., Smith J. A., Golenbock D. T., Gazzinelli R. T., Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite Journal of Immunology 2001 167 1 416 423 (Pubitemid 32567807)
36. Piedrafita D., Proudfoot L., Nikolaev A. V., Xu D., Sands W., Feng G. J., Thomas E., Brewer J., Ferguson M. A. J., Alexander J., Liew F. Y., Regulation of macrophage IL-12 synthesis by leishmania phosphoglycans European Journal of Immunology 1999 29 1 235 244 (Pubitemid 29043541)
37. Muraille E., De Trez C., Brait M., De Baetselier P., Leo O., Carlier Y., Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response Journal of Immunology 2003 170 8 4237 4241 (Pubitemid 36428190)
38. Debus A., Glsner J., Rllinghoff M., Gessner A., High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent Infection and Immunity 2003 71 12 7215 7218 (Pubitemid 37475361)
39. De Trez C., Brait M., Leo O., Aebischer T., Torrentera F. A., Carlier Y., Muraille E., Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species Infection and Immunity 2004 72 2 824 832 (Pubitemid 38166661)
40. Muzio M., Ni J., Feng P., Dixit V. M., IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL- 1 signaling Science 1997 278 5343 1612 1615 (Pubitemid 27516277)
41. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., Akira S., Differential involvement of IFN- in toll-like receptor-stimulated dendritic cell activation International Immunology 2002 14 10 1225 1231 (Pubitemid 35175229)
42. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L. G., Ruiz A., Cervantes R., Torres A. P., Cabrera N., Gonzlez A., Maldonado C., Isibasi A., Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2 Molecular and Biochemical Parasitology 2003 130 2 65 74 (Pubitemid 37289124)
43. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., Kishimoto T., SOCS-1 participates in negative regulation of LPS responses Immunity 2002 17 5 677 687 (Pubitemid 35351512)
44. Kavoosi G., Ardestani S. K., Kariminia A., Alimohammadian M. H., Leishmania major lipophosphoglycan: discrepancy in toll-like receptor signaling Experimental Parasitology 2010 124 2 214 218
45. Bhattacharya P., Bhattacharjee S., Gupta G., Majumder S., Adhikari A., Mukherjee A., Majumdar S. B., Saha B., Majumdar S., Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of Toll-Like receptor 2 signaling: an immunoprophylactic approach Journal of Infectious Diseases 2010 202 1 145 155
46. Dogra N., Warburton C., McMaster W. R., Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective Infection and Immunity 2007 75 7 3506 3515 (Pubitemid 47040952)
47. Vivarini. D. C., Pereira R. D. M. S., Teixeira K. L. D., Calegari-Silva T. C., Bellio M., Laurenti M. D., Corbett C. E. P., Gomes C. M. D. C., Soares R. P., Silva A. M., Silveira F. T., Lopes U. G., Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2 FASEB Journal 2011 25 12 4162 4173
48. Kropf P., Freudenberg M. A., Modolell M., Price H. P., Herath S., Antoniazi S., Galanos C., Smith D. F., Mller I., Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major Infection and Immunity 2004 72 4 1920 1928 (Pubitemid 38419902)
49. Srivastava A., Singh N., Mishra M., Kumar V., Gour J. K., Bajpai S., Singh S., Pandey H. P., Singh R. K., Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens Molecular and Cellular Biochemistry 2011 359 1-2 359 368
50. Cezrio G. A.G., de Oliveira L. R.C., Peresi E., Nicolete V. C., Polettini J., de Lima C. R.G., Gatto M., Calvi S. A., Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental leishmania chagasi infection Memorias do Instituto Oswaldo Cruz 2011 106 5 573 583
51. Gallego C., Golenbock D., Gomez M. A., Saravia N. G., Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis Infection and Immunity 2011 79 7 2871 2879
52. Charmoy M., Megnekou R., Allenbach C., Zweifel C., Perez C., Monnat K., Breton M., Ronet C., Launois P., Tacchini-Cottier F., Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection Journal of Leukocyte Biology 2007 82 2 288 299 (Pubitemid 47230640)
53. Silvestre R., Silva A. M., Cordeiro-Da-Silva A., Ouaissi A., The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein Immunology 2009 128 4 484 499
54. Chandra D., Naik S., Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism Clinical and Experimental Immunology 2008 154 2 224 234
55. Abu-Dayyeh I., Shio M. T., Sato S., Akira S., Cousineau B., Olivier M., Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif PLoS Neglected Tropical Diseases 2008 2 12, article e305
56. Vargas-Inchaustegui D. A., Tai W., Xin L., Hogg A. E., Corry D. B., Soong L., Distinct roles for MyD88 and toll-like receptor 2 during Leishmania braziliensis infection in mice Infection and Immunity 2009 77 7 2948 2956
57. Guerra C. S., Macedo Silva R. M., Carvalho L. O. P., Calabrese K. D. S., Bozza P. T., Crte-Real S., Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis International Journal of Experimental Pathology 2010 91 5 451 459
58. Pereira R. M. S., Teixeira K. L. D., Barreto-de-Souza V., Calegari-Silva T. C., De-Melo L. D. B., Soares D. C., Bou-Habib D. C., Silva A. M., Saraiva E. M., Lopes U. G., Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania FASEB Journal 2010 24 2 617 626
59. Kropf P., Freudenberg N., Kalis C., Modolell M., Herath S., Galanos C., Freudenberg M., Mller I., Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication Journal of Leukocyte Biology 2004 76 1 48 57 (Pubitemid 38857171)
60. Antoniazi S., Price H. P., Kropf P., Freudenberg M. A., Galanos C., Smith D. F., Mller I., Chemokine gene expression in Toll-like receptor-competent and -deficient mice infected with Leishmania major Infection and Immunity 2004 72 9 5168 5174 (Pubitemid 39223402)
61. Wang N., Satoskar A., Faubion W., Howie D., Okamoto S., Feske S., Gullo C., Clarke K., Sosa M. R., Sharpe A. H., Terhorst C., The cell surface receptor SLAM controls T cell and macrophage functions Journal of Experimental Medicine 2004 199 9 1255 1264 (Pubitemid 38620262)
62. Whitaker S. M., Colmenares M., Pestana K. G., McMahon-Pratt D., Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4 Infection and Immunity 2008 76 5 2149 2156 (Pubitemid 351656149)
63. Colmenares M., Tiemeyer M., Kima P., McMahon-Pratt D., Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8 Infection and Immunity 2001 69 11 6776 6784 (Pubitemid 32995436)
64. Shweash M., Adrienne McGachy H., Schroeder J., Neamatallah T., Bryant C. E., Millington O., Mottram J. C., Alexander J., Plevin R., Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression Molecular Immunology 2011 48 15-16 1800 1808
65. Mahieu T., Park J. M., Revets H., Pasche B., Lengeling A., Staelens J., Wullaert A., Vanlaere I., Hochepied T., Van Roy F., Karin M., Libert C., The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN- production Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2292 2297 (Pubitemid 43271663)
66. Jones L. A., Anthony J. P., Henriquez F. L., Lyons R. E., Nickdel M. B., Carter K. C., Alexander J., Roberts C. W., Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors Immunology 2008 125 1 59 69
67. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., Khl J., C5a negatively regulates toll-like receptor 4-induced immune responses Immunity 2005 22 4 415 426 (Pubitemid 40545108)
68. Ribeiro-Gomes F. L., Otero A. C., Gomes N. A., Moniz-De-Souza M. C. A., Cysne-Finkelstein L., Arnholdt A. C., Calich V. L., Coutinho S. G., Lopes M. F., DosReis G. A., Macrophage Interactions with Neutrophils Regulate Leishmania major Infection Journal of Immunology 2004 172 7 4454 4462 (Pubitemid 38375261)
69. Ribeiro-Gomes F. L., Moniz-de-Souza M. C. A., Alexandre-Moreira M. S., Dias W. B., Lopes M. F., Nunes M. P., Lungarella G., DosReis G. A., Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase Journal of Immunology 2007 179 6 3988 3994
70. Filardy A. A., Pires D. R., Nunes M. P., Takiya C. M., Freire-de-Lima C. G., Ribeiro-Gomes F. L., DosReis G. A., Proinflammatory clearance of apoptotic neutrophils induces an IL-12 lowIL-10high regulatory phenotype in macrophages Journal of Immunology 2010 185 4 2044 2050
71. Faria M. S., Reis F. C.G., Azevedo-Pereira R. L., Morrison L. S., Mottram J. C., Lima A. P.C.A., Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages Journal of Immunology 2011 186 1 411 422
72. Eschenlauer S. C. P., Faria M. S., Morrison L. S., Bland N., Ribeiro-Gomes F. L., Dosreis G. A., Coombs G. H., Lima A. P. C. A., Mottram J. C., Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major Cellular Microbiology 2009 11 1 106 120
73. Perera P. Y., Mayadas T. N., Takeuchi S., Akira O., Zaks-Zilberman M., Goyert S. M., Vogel S. N., CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression Journal of Immunology 2001 166 1 574 581 (Pubitemid 32038479)
74. Ajdary S., Ghamilouie M. M., Alimohammadian M. H., Riazi-Rad F., Pakzad S. R., Toll-like receptor 4 polymorphisms predispose to cutaneous leishmaniasis Microbes and Infection 2011 13 3 226 231
75. Brzezinska A. A., Johnson J. L., Munafo D. B., Ellis B. A., Catz S. D., Signalling mechanisms for Toll-like receptor-activated neutrophil exocytosis: key roles for interleukin-1-receptor-associated kinase-4 and phosphatidylinositol 3-kinase but not Toll/IL-1 receptor (TIR) domain-containing adaptor inducing IFN- (TRIF) Immunology 2009 127 3 386 397
76. Li Y., Ishii K., Hisaeda H., Hamano S., Zhang M., Nakanishi K., Yoshimoto T., Hemmi H., Takeda K., Akira S., Iwakura Y., Himeno K., IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9? Gene Therapy 2004 11 11 941 948 (Pubitemid 38786609)
77. Liese J., Schleicher U., Bogdan C., TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis European Journal of Immunology 2007 37 12 3424 3434
78. Schleicher U., Liese J., Knippertz I., Kurzmann C., Hesse A., Heit A., Fischer J. A. A., Weiss S., Kalinke U., Kunz S., Bogdan C., NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs Journal of Experimental Medicine 2007 204 4 893 906 (Pubitemid 46631617)
79. Fakher F. H. A., Rachinel N., Klimczak M., Louis J., Doyen N., TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors TH1 cell development and the resolution of lesions Journal of Immunology 2009 182 3 1386 1396
80. Bogdan C., Schleicher U., Comment on TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions Journal of Immunology 2009 183 11 6859
81. Flandin J. F., Chano F., Descoteaux A., RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon- -primed macrophages European Journal of Immunology 2006 36 2 411 420 (Pubitemid 43257464)
82. Ives A., Ronet C., Prevel F., Ruzzante G., Fuertes-Marraco S., Schutz F., Zangger H., Revaz-Breton M., Lye L.-F., Hickerson S. M., Beverley S. M., Acha-Orbea H., Launois P., Fasel N., Masina S., Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis Science 2011 331 6018 775 778
83. Shamshiev A. T., Ampenberger F., Ernst B., Rohrer L., Marsland B. J., Kopf M., Dyslipidemia inhibits Toll-like receptor-induced activation of CD8 -negative dendritic cells and protective Th1 type immunity Journal of Experimental Medicine 2007 204 2 441 452 (Pubitemid 46294558)
84. Stacey K. J., Blackwell J. M., Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major Infection and Immunity 1999 67 8 3719 3726 (Pubitemid 29356983)
85. Skeiky Y. A. W., Coler R. N., Brannon M., Stromberg E., Greeson K., Thomas Crane R., Campos-Neto A., Reed S. G., Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant Vaccine 2002 20 27-28 3292 3303 (Pubitemid 35245813)
86. Calvopina M., Barroso P. A., Marco J. D., Korenaga M., Cooper P. J., Nonaka S., Hashiguchi Y., Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis Vaccine 2006 24 27-28 5645 5652 (Pubitemid 43867099)
87. Tewary P., Mehta J., Sukumaran B., Madhubala R., Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection FEMS Immunology and Medical Microbiology 2004 42 2 241 248 (Pubitemid 39208553)
88. Tewary P., Sukumaran B., Saxena S., Madhubala R., Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen Vaccine 2004 22 23-24 3053 3060 (Pubitemid 39037207)
89. Badiee A., Jaafari M. R., Samiei A., Soroush D., Khamesipour A., Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice Clinical and Vaccine Immunology 2008 15 4 668 674 (Pubitemid 351967047)
90. Iborra S., Parody N., Abnades D. R., Bonay P., Prates D., Novais F. O., Barral-Netto M., Alonso C., Soto M., Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice Microbes and Infection 2008 10 10-11 1133 1141
91. Ramirez L., Iborra S., Cortes J., BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge Journal of Biomedicine and Biotechnology 2010 2010 9
92. Puig M., Grajkowski A., Boczkowska M., Ausn C., Beaucage S. L., Verthelyi D., Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates Nucleic Acids Research 2006 34 22 6488 6495 (Pubitemid 46017945)
93. Daifalla N. S., Bayih A. G., Gedamu L., Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB/c mice: the contribution of Toll-like receptor agonists as adjuvant Experimental Parasitology 2011 129 3 292 298
94. Zhang W. W., Matlashewski G., Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice Infection and Immunity 2008 76 8 3777 3783
95. Raman V. S., Bhatia A., Picone A., Whittle J., Bailor H. R., O'Donnell J., Pattabhi S., Guderian J. A., Mohamath R., Duthie M. S., Reed S. G., Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis Journal of Immunology 2010 185 3 1701 1710
96. Hernndez-Ruiz J., Salaiza-Suazo N., Carrada G., Escoto S., Ruiz-Remigio A., Rosenstein Y., Zentella A., Becker I., CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists PLoS Neglected Tropical Diseases 2010 4 11, article e871
97. Jayakumar A., Castilho T. M., Park E., Goldsmith-Pestana K., Blackwell J. M., McMahon-Pratt D., TLR1/2 activation during Heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T cell responses providing protection against Leishmania (Viannia) PLoS Neglected Tropical Diseases 2011 5 6, article e1204